Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Of mice and men and surgical transcatheter aortic valve insertion

Manuel J. Antunes, MD, PhD, DSc

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD

Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic.

Sergey Leontyev, MD, Michael A

Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis Evaldas Girdauskas,

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Jennifer Chung, MD, MSc, Maral Ouzounian, MD, PhD

Form ever follows function

Multilevel data analysis: What? Why? How?

Bicuspid aortic valve aortopathy: One size fits all?

Long-term results of aortic valve–sparing operations in patients with Marfan syndrome Tirone E. David, MD, Sue Armstrong, BSc, Manjula Maganti, BSc, Jack.

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment Herko Grubitzsch, MD, PhD, Andreas Schaefer, Christoph.

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome Kevin G. Soucy, PhD, Steven.

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

John A. Elefteriades, MD, PhD (hon), Bulat A. Ziganshin, MD, PhD

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

Michele Gallo, MD, Gino Gerosa, MD

Stentless biological valved conduit for aortic root replacement: Initial experience with the Shelhigh BioConduit model NR-2000C Abdullah Kaya, MD, Robin.

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Torsten Doenst, MD, PhD, Markus Richter, MD

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

The Journal of Thoracic and Cardiovascular Surgery

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Valve performance classification in 630 subcoronary Ross patients over 22 years Hans-Hinrich Sievers, MD, Ulrich Stierle, MD, Michael Petersen, MD, Stefan.

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Replicating the success of mitral valve repair in the aortic valve

Bradley G. Leshnower, MD, Robert A. Guyton, MD, Richard J

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Biomaterials for heart valve replacement: Conjectures and refutations

The Mitroflow aortic valve: A past, present, and future illuminated

Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD

Hans-Joachim Schäfers, MD

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend G. Michael Deeb, MD, John Carroll, MD The Journal.

The harder one looks, the more one finds

Concomitant replacement of the ascending aorta is free—for some

Long-term results of Freestyle stentless bioprosthesis in the aortic position: A single- center prospective cohort of 500 patients Nicolas Amabile, MD,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Between a rock and a hard place

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

How do we follow up our patients

Thanos Sioris, MD, Tirone E

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ, MD, Herko Grubitzsch, MD, PhD, Benjamin Claus, MD, Wolfgang Konertz, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 147, Issue 1, Pages 264-269 (January 2014) DOI: 10.1016/j.jtcvs.2012.10.032 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Survival of study population compared with general population and patients with normal left ventricular function, isolated aortic valve procedure, and stenotic valve lesion. EPP, Edwards Prima Plus. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 264-269DOI: (10.1016/j.jtcvs.2012.10.032) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Freedom from reoperation of total study population and stratified by diameter of Edwards Prima Plus (EPP). The Journal of Thoracic and Cardiovascular Surgery 2014 147, 264-269DOI: (10.1016/j.jtcvs.2012.10.032) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions